Comparison of 4 Diets Dansinger, et al (2005). Comparison of Atkins, Ornish, Weight Watchers and Zone Diets for Weight Loss and Heart Disease Risk Reduction,

Slides:



Advertisements
Similar presentations
Popular Diets Gil C. Grimes, MD Assistant Professor Family Medicine Texas A&M HSC COM Scott and White Family Medicine Residency April 9 th 2005.
Advertisements

CLINICAL DILEMMAS IN OBESITY MANAGEMENT
OmniHeart Feeding Study Presented at The American Heart Association Scientific Session 2005 Presented by Dr. Lawrence J. Appel OmniHeart Feeding Study.
Presented By: Nancy Health Coach
Survival Analysis In many medical studies, the primary endpoint is time until an event occurs (e.g. death, remission) Data are typically subject to censoring.
Clinical Trial Results. org Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson’s Disease Renzo Zanettini, M.D.; Angelo Antonini, M.D.;
**************** GCRC Research-Skills Workshop October 26, 2007 William D. Dupont Department of Biostatistics **************** How to do Power & Sample.
Definitions Body Mass Index (BMI) describes relative weight for height: weight (kg)/height (m 2 ) Overweight = 25–29.9 BMI Obesity = >30 BMI.
CONTROLLING YOUR RISK FACTORS Taking the Steps to a Healthy Heart.
Slide Source: Lipids Online Slide Library 56 healthy premenopausal obese women (aged 25–44 years) compared with 40 age-matched nonobese.
Introductions Name address Favorite type of food Least favorite food Magazine you read most often All-time favorite movie Concert/performance you’d.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Clinical Goals for the Healthy.
Chapter 14 Conducting & Reading Research Baumgartner et al Chapter 14 Inferential Data Analysis.
Effectiveness of interactive web-based lifestyle program on prevention of cardiovascular diseases risk factors in patient with metabolic syndrome: a randomized.
Baseline. Caloric Balance Caloric Intake + Expenditure = +/- Caloric Balance.
Uncontrolled Hypertension, Systolic and Diastolic Blood Pressure and Development of Symptomatic Peripheral Arterial Disease in the Women’s Health Study.
+ Were Hunters and Gatherers Really Healthier Than Us? An Evidence Based Look at the Paleolithic Diet By: Kelsey Starck.
OBESITY: WHICH DIET IS BEST? Ronen Gurfinkel, PGY4 May 30, 2012.
The Effectiveness of Weight Watchers By Leana Scherer …OR DOES IT?
Minimally Invasive Surgery Symposium Modest Weight Loss in T2 DM: Lessons from the Look AHEAD Trial Donna H. Ryan, MD Pennington Biomedical Research Center.
Results of Monotherapy in ALLHAT: On-treatment Analyses ALLHAT Outcomes for participants who received no step-up drugs.
Low level of high density lipoprotein cholesterol in children of patients with premature coronary heart disease. Relation to own and parental characteristics.
Using Healthy Heart Data by Rick Frey, PhD Toiyabe Indian Health Project, Inc. A collection of PowerPoint slides that have been used in grant applications,
Memory in Elders: Food for Thought Summary and Comment by Jonathan Silver, MD Published in Journal Watch Psychiatry March 9, 2009Journal Watch Psychiatry.
Organizational criteria for Metabolic Syndrome National Cholesterol Education Program Adult Treatment Panel III World Health OrganizationAmerican Association.
Potatoes or Bacon: Which is better for weight loss? Laura Zakowski, MD.
A Randomized Placebo- Controlled Trial of Metformin for the Treatment of HIV Lipodystrophy Rakhi Kohli MD MS, Christine Wanke MD, Sherwood Gorbach MD,
Farid Saad Euro Weight Loss-2015 Frankfurt, Germany August 18 – 20, 2015.
The COMBINE Study: Design and Methodology Stephanie S. O’Malley, Ph.D. for The COMBINE Study Research Group JAMA Vol. 295, , 2006 (May 3 rd.
VBWG PROactive: Study design Dormandy JA et al. Lancet. 2005;366: Charbonnel B et al. Diabetes Care. 2004;27: Objective: Assess the effects.
© 2004, Wellsource Inc. Low Carbohydrate Diet and LDL Cholesterol Levels 119 men and women, 24 weeks On the low carb diet, LDL increased slightly On low.
Effects on Weight of a Cluster-Randomized, Controlled Trial of a Faith-based Adaption of the Diabetes Prevention Program within African-American Churches.
Date of download: 5/29/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of a Fixed-Dose Combination Strategy on Adherence.
Health differences between adolescents who commute actively to school and those who travel by vehicle David A. Rowe FACSM 1, Non Thomas 2, Rhys Williams.
Date of download: 7/5/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of High vs Low Glycemic Index of Dietary Carbohydrate.
Date of download: 7/8/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Comparison of the Atkins, Ornish, Weight Watchers,
Multicenter, Placebo-Controlled Trial
RESULTS OF THE RIMONABANT IN OBESITY (RIO) PROGRAM AT 1 YEAR
Baseline Characteristics of Women and Men in Whom Coronary Heart Disease Developed during Follow-up and Matched Controls - A Jennifer K. Pai et al. N.
Copyright © 2007 American Medical Association. All rights reserved.
HbA1c 1245_0025final study-report-body. Table : 1 HbA1c (%) change from baseline MMRM results over time − FAS (OC−AD)
by Sarah Steinmetz and Amber Brouillette
23 Studies Source: authoritynutrition.com
Supplementary material
Comparison of baseline characteristics in participants who subsequently had an incident cardiovascular event or new-onset diabetes in the Prospective.
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults Risks and Assessment NHLBI Obesity Education.
End point Rimonabant 20 mg (n=339) Placebo (n=348) p Weight (kg) -5.3
How to use the PS sample size software for advanced applications
Kendra K. Kattelmann, PhD, RD: South Dakota State University (SDSU)
Systolic Blood Pressure Intervention Trial (SPRINT)
Associations of Diet and Lifestyle with Hyperlipidemia for the Middle-Aged and Elderly in the Guangxi Bai Ku Yao and Han Populations Yin Ruixing, MD: Guangxi.
Cholesterol and blood pressure values at baseline and after 15 days of dark-chocolate and white-chocolate consumption Characteristic Dark chocolate before.
Copyright, Disease Management Strategy Group, 2012
Sodium-glucose co-transporter 2 (SGLT2) inhibitors work by blocking the reabsorption of filtered glucose in the kidneys. This leads to glucosuria and improved.
Placebo group 5-mg rimonabant group p 20-mg rimonabant group
Metabolic Syndrome (N=160) Non-Metabolic Syndrome (N=138) 107/53
DiRECT (Diabetes Remission Clinical Trial)
Time point Difference in systolic BP (mm Hg) p
Section overview: Cardiometabolic risk reduction
A B D C Total adiponectin (μg/ml ) Hb ( g / dl ) r = p = 0.003
Level of risk factor control in the overall sample and by gender
OmniHeart Feeding Study
Kendra K. Kattelmann, PhD, RD: South Dakota State University (SDSU)
Clinical Characteristics and Atheroma Burden of Subjects at Baseline Stratified According to Gender Nicholls SJ. et al. J Am Coll Cardiol 2007;49:
Flow of Patients Through Trial
Change in (A) total cholesterol; (B) LDL-cholesterol; (C) HDL-cholesterol and (D) triglycerides over 5 years in response to 12-week intensive lifestyle.
The Healthy Beverage Index Is Associated with Reduced Cardio-metabolic Risk in US Adults: A Preliminary Analysis Kiyah J. Duffey, PhD Brenda M. Davy, PhD,
Obesity Eppie Habashi.
Exercise 1 Use Transform  Compute variable to calculate weight lost by each person Calculate the overall mean weight lost Calculate the means and standard.
Changes of major clinical and biochemical characteristics at baseline and during follow-up in different groups. Changes of major clinical and biochemical.
Presentation transcript:

Comparison of 4 Diets Dansinger, et al (2005). Comparison of Atkins, Ornish, Weight Watchers and Zone Diets for Weight Loss and Heart Disease Risk Reduction, JAMA. 293:43-53

Setting Started with 1010 Telephone Inquiries 763 Excluded (No interest, too busy, not in range of BMI (27-42), insulin, unknown) 247 Screened in person-87 excluded for various reasons 160 Randomized –40 Atkins –40 Zone –40 Weight Watchers –40 Ornish (Vegetarian)

Primary Measures Changes from baseline taken at 2, 6, 12 months: –Weight (kg) –BMI –Waist Circumference (cm) –Total, LDL, HDL Cholesterol (mg/dL) –Total/LDL and Total/HDL cholesterol ratios –Triglycerides (mg/dL) –Systolic and Diastolic BP (mm Hg) –Glucose (mg/dL) –Insulin ( IU/mL) –C-reactive protein (mg/L) –Whether or not stayed on diet

Miscellaneous Issues Diets were considered to be ordered in terms of extremity: Atkins < Zone < Weight Watchers < Ornish Analyses were conducted at 3 points in time: 2 months, 6 months, 12 months Controlled for: dietary adherence, cardiac risk factors, baseline characteristics, exercise changes, medication Analyzed two sets of individuals: –All subjects randomized with baseline measure carried forward if dropped out (intent-to-treat) –Those subjects who were continuing in the study (completed protocol aka study completers)

Tests Reported At each point in time for each measure, the authors gave the diets levels of X=1, 2, 3, 4 based on the ordering of their extremity They then fit a simple regression, relating the level of the measure (change from baseline with missing values being set at 0, no change) to the diet level, and obtained the Pearson correlation They then tested H 0 : = 0 vs H A : 0 with the t-test:

Comparison of Weight 12 Months Note that authors report P-value of.40 (round-off differences)

Alternative Tests The authors tests are very restrictive regarding the diet means: –The diets are equally spaced wrt extremity –The means will vary in a linear fashion in H A. Consider a more general alternative (the means are simply not all equal). H 0 : A = Z = W = O H A : Means not all equal Conduct the F-test based on Completely Randomized Design

1-Way ANOVA Note still no evidence of diet differences.

Test of Differences in Attrition (Chi-Square) Atkins: 21 of 40 still participating at 12 months Zone: 26 of 40 still participating at 12 months Weight Watchers: 26 of 40 still participating at 12 months Ornish: 21 of 40 still participating at 12 months Overall: 93 of 160 still participating at 12 months Test Statistic: X obs 2 =3.158 P-value=P(X ) =

Other Possible Analysis Repeated Measures ANOVA –Diet Effects (4-1=3 df) –Subject(Diet) Effects (4(40-1)=156 df) –Time Effects (3-1=2 df) –Diet x Time Interaction (3(2)=6 df) –Error (Time x Subject(Diet) Interaction) (2(156)=312 df)